Arkolith/Insider Trading/ATXI/Form 4

InvaGen Pharmaceuticals, Inc.

10% OwnerAVENUE THERAPEUTICS, INC. (ATXI) · full profile →Form 4 · filed Oct 13, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$3.0M
Net Open-Market Flow
-$3.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 11, 2022Sell(S)389K$7.71$3.0M0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-108589) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML